Solitaire FR device for treatment of dural sinus thrombosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23299102.
- Also identified by DOI 10.1136/neurintsurg-2012-010543.rep.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dural venous sinus thrombosis is a rare and potentially devastating disease. Several predisposing factors exist, including oral contraceptive therapy and colitis. First-line therapy consists of systemic anticoagulation. If first-line therapies fail, more aggressive endovascular therapies may be performed. We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus thrombosis.
Medical subject headings
- Endovascular Procedures
- Sinus Thrombosis, Intracranial